NGH

MARKHAM, ON, April 7 /CNW/ -- Offering to be made available to the Company's more than 3,000 EMR users in Canada and all new customers MARKHAM, ON, April 7 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) ("Nightingale" or the "Company"), an application service provider (ASP) of Electronic Medical Record (EMR) software and related services today announces that its leading, web-based EMR and practice management solution, Nightingale On Demand, is now commercially available for use on the Apple(®) iPad™. Nightingale On Demand for the iPad™ responds to the increasing need for physicians and healthcare providers to have mobile access to their patient data. Key functionalities of the application will allow physicians to review patient charts and lab results, respond to patient and staff messages, as well as manage the scheduling and billing of patient visits. This is a complimentary tool for physicians using Nightingale On Demand and has been designed with use in settings, such as hospital rounds or offsite patient management and homecare, in mind. "We are pleased to offer Nightingale On Demand to our customers for use on the iPad™," said Sam Chebib, President and CEO of Nightingale. "Product innovation is a cornerstone of the Company's mandate. We strive to provide solutions that not only make EMR implementation easier for physicians but also leverage the most current technology available in the marketplace.  We are confident that this will be a significant value added product offering for our customers. As a result, we anticipate considerable uptake over the coming months." Nightingale is leading the Canadian EMR market as one of the first companies with plans to launch an iPad™-enabled solution. Physicians and healthcare providers will have the comfort of knowing that all patient data entered while using the iPad™ is stored directly to the same secure servers Nightingale uses for its existing ASP EMR, and that no patient data will remain on the iPad™ device. Nightingale On Demand for the iPad™ will be made available to the Company's more than 3,000 EMR users in Canada, as well as all new EMR customers. About Nightingale Informatix Corporation Nightingale is one of the fastest growing healthcare service and software companies in North America. It is recognized as an industry leader in web based (ASP) clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base.  Nightingale - Healthcare connected.  www.nightingalemd.com Forward Looking Statement This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully integrate its acquisitions and any liabilities arising as a result of such acquisitions, access to capital and agreements with its Lenders; the existence of present and possible future government regulation; access to debt or equity financing and agreements with its Lenders; the significant and increasing competition that exists in the medical software industry; the early stage of Nightingale's business; and therefore it is subject to the risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding.  All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Although management believes the assumptions used to make such statements are reasonable at this time, our assumptions may not to be as anticipated, estimated or intended. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding Nightingale's continued ability to fund its business, rates of customer defaults, relationships with, and payments to, lenders, demand for Nightingale's products, as well as Nightingale's operating cost structure. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/April2011/07/c2111.html table cellspacing="0" valign="top" border="0" tr valign="top" td align="left" bMedia Inquiries/bbr/ Michael McMillanbr/ Veritas Communicationsbr/ T 416.955.4583br/ a href="mailto:modesto@veritascanada.com"macmillan@veritascanada.com/a /td td align="left" /td td align="left" /td td align="left" /td td align="left" /td td align="left" /td td align="left" valign="top" bInvestor Inquiries/bbr/ Kristen Dickson, M.Sc.br/ Equicom, a TMX Group Companybr/ Tel: 416.815.0700 ext. 273br/ a href="mailto:kdickson@equicomgroup.com"kdickson@equicomgroup.com/a /td /tr /table

Copyright